About the Company
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NAVB News
Navidea Biopharmaceuticals gets grant for method for conjugating metal chelating agent to functionalized dextran
Discover Navidea Biopharmaceuticals Inc's innovative patent for conjugating metal chelating agents to dextran, free of crosslinking. Explore its potential in medical imaging and drug delivery.
Navidea Biopharmaceuticals, Inc. (NAVB)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Sarah Kathryn Rouan's Net Worth
This is based on reported shares across multiple companies, which include Viking Therapeutics, Inc., and NAVIDEA BIOPHARMACEUTICALS, INC..
Navidea Biopharma (NAVB) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
GlucoTrack, Inc. (NASDAQ: GCTK ... with high cross-reactivity to multiple strains of influenza. Navidea Biopharmaceuticals (NASDAQ: NCMI) fell 17.5% to $0.3526. The company recently filed a ...
Navidea Biopharmaceuticals Inc NAVB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Navidea Biopharmaceuticals Inc NAVB
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Navidea Biopharmaceuticals, Inc. (NAVB)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Navidea Biopharmaceuticals, Inc (NAVB)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Navidea Biopharmaceuticals, Inc. (NAVB)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...